Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS-MPH for ADHD in Adolescents with SUD
NCT00264797Phase 3Completed
- Sponsor
- University of Cincinnati
- Start
- Feb 2006
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University of Cincinnati. Started Feb 2006; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00264797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00264797.